3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 — Oct 15th, 2024

Axsome Therapeutics, Inc. NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial results for the thi...

1 Under-the-Radar Biotech Stock to Buy and Hold — Sep 29th, 2024

Companies with exciting prospects aren't always of the popular, headline-grabbing variety. Some little-known stocks are worth serious consideration, too. Take Axsome Therapeutics(NASDAQ: AXSM), a mid-cap biotech company not involved in the rapidly growing area of GLP-1 weight loss drugs. ...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 — Oct 15th, 2024

Axsome Therapeutics, Inc. NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial results for the thi...

1 Under-the-Radar Biotech Stock to Buy and Hold — Sep 29th, 2024

Companies with exciting prospects aren't always of the popular, headline-grabbing variety. Some little-known stocks are worth serious consideration, too. Take Axsome Therapeutics(NASDAQ: AXSM), a mid-cap biotech company not involved in the rapidly growing area of GLP-1 weight loss drugs. ...

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 — Oct 15th, 2024

Axsome Therapeutics, Inc. NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial results for the thi...

1 Under-the-Radar Biotech Stock to Buy and Hold — Sep 29th, 2024

Companies with exciting prospects aren't always of the popular, headline-grabbing variety. Some little-known stocks are worth serious consideration, too. Take Axsome Therapeutics(NASDAQ: AXSM), a mid-cap biotech company not involved in the rapidly growing area of GLP-1 weight loss drugs. ...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 — Oct 15th, 2024

Axsome Therapeutics, Inc. NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial results for the thi...

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 — Oct 15th, 2024

Axsome Therapeutics, Inc. NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial results for the thi...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024 — Sep 24th, 2024

Axsome Therapeutics, Inc. Seven presentations highlight the Company’s growing CNS portfolio and commitment to improving treatment outcomes for patients with sleep disorders NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical compan...

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 — Oct 15th, 2024

Axsome Therapeutics, Inc. NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial results for the thi...

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 — Oct 15th, 2024

Axsome Therapeutics, Inc. NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial results for the thi...

1 Under-the-Radar Biotech Stock to Buy and Hold — Sep 29th, 2024

Companies with exciting prospects aren't always of the popular, headline-grabbing variety. Some little-known stocks are worth serious consideration, too. Take Axsome Therapeutics(NASDAQ: AXSM), a mid-cap biotech company not involved in the rapidly growing area of GLP-1 weight loss drugs. ...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

1 Under-the-Radar Biotech Stock to Buy and Hold — Sep 29th, 2024

Companies with exciting prospects aren't always of the popular, headline-grabbing variety. Some little-known stocks are worth serious consideration, too. Take Axsome Therapeutics(NASDAQ: AXSM), a mid-cap biotech company not involved in the rapidly growing area of GLP-1 weight loss drugs. ...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 — Oct 15th, 2024

Axsome Therapeutics, Inc. NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will report its financial results for the thi...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...

1 Under-the-Radar Biotech Stock to Buy and Hold — Sep 29th, 2024

Companies with exciting prospects aren't always of the popular, headline-grabbing variety. Some little-known stocks are worth serious consideration, too. Take Axsome Therapeutics(NASDAQ: AXSM), a mid-cap biotech company not involved in the rapidly growing area of GLP-1 weight loss drugs. ...

3 Bargain Stocks to Buy in a Market That's Priced for Perfection — Oct 19th, 2024

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to roughly $277 billion. When Buffett is sitting on that much cash because he can't find appealing investments to buy, you know stocks are expensive. There are except...